A new pre-wedding trend is taking shape across India’s metros, where clinics are offering weight-loss injections alongside bridal makeovers. Labelled “Mounjaro brides”, it reflects a shift towards time-bound, medically assisted slimming before the wedding day.

Clinics package injections into pre-wedding plans

Aesthetic and wellness centres in cities such as Delhi and Mumbai are promoting GLP-1 drugs, including Mounjaro and Wegovy, within bridal packages traditionally focused on skin and hair. Some advertise structured plans combining nutrition, exercise and weekly injections, while others position the offering more discreetly.

Clinic responses to prospective clients show a clear sales pattern: quick consultations, BMI checks and an emphasis on timelines tied to wedding dates. Doctors report a rise in enquiries from soon-to-be brides and, increasingly, grooms. In some practices, a notable share of requests for obesity injections now comes from those preparing for marriage.

How the drugs work and what they cost

GLP-1 drugs are designed to suppress appetite by slowing digestion, helping patients feel full for longer. Treatment typically involves weekly injections, starting at low doses and increasing based on tolerance and response.

Costs vary widely. Monthly Mounjaro doses range from about ₹13,125 to ₹25,781, while Wegovy is priced lower. Cheaper versions have begun entering the market, reducing per-dose costs in some clinics but still pushing total treatment expenses into tens of thousands of rupees over a few months.

These medicines are approved for obesity and related conditions such as diabetes or hypertension, and are meant to be used under medical supervision.

Wedding pressure and fast results

The demand is shaped by the scale and expectations of Indian weddings, where appearance often carries social weight. Some users report turning to injections after diet and exercise failed to deliver results within limited timelines. Others cite body-shaming during matchmaking as a trigger.

Patients interviewed described noticeable weight loss ahead of their weddings, with many discontinuing treatment soon after.

Safety questions and regulatory scrutiny

Doctors stress that prescriptions are typically limited to medically eligible patients, not cosmetic use. They point to side effects such as nausea and bloating, and highlight limited long-term data on newer treatments.

India’s drug regulator has also raised concerns about misuse and stepped up scrutiny of unauthorised sales and promotion. The issue has drawn political attention, with questions over how such drugs are marketed within the wedding industry.

At the same time, India’s obesity burden is rising sharply, with projections suggesting hundreds of millions could be overweight or obese by 2050, expanding the potential market for these therapies.